Montreal, Quebec – November 10, 2021 – Emovi, Inc., a leading medical device developer and manufacturer for orthopaedics, will unveil its functional knee assessment device, the KneeKG™ system, to the United States imaging market during the 2021 Radiological Society of North America (RSNA). The RSNA annual conference is being held November 28 through December 1 in Chicago, IL.
Emovi will present the KneeKG system in the Innovation Theater on November 30 at noon local time. Emovi is also hosting an exclusive session called, “Redefining Traditional Static Knee Exams with Dynamic Information using the KneeKG™ system,” on December 1 at 1:30 pm to present how the dynamic functional assessment can help overcome the limitations of static information from x-rays and MRI for the management of knee osteoarthritis, ligament injuries, anterior knee pain, and for pre-operative and post-operative total knee replacement programs.
“We are eager to launch our technology in the field of radiology, specifically, as pressure builds around the need to enhance diagnosis and patient communication,” said Michelle Laflamme, President and CEO Emovi. “Every year in the US, there are about 19 million medical consultations for knee problems, and the majority result in an X-ray or MRI, which are sometimes limited in terms of clinical and actionable responses. The AI-powered KneeKGTM technology supports the static images with 3D information of the loaded knee for more precise and robust data on the causes of functional knee pain, ultimately allowing clinicians to provide better, more complete patient care.”
The KneeKG system is a portable, validated, FDA (510k) cleared medical device capable of assessing knee motion for patients with impaired movement functions of an orthopedic cause, complementing the x-ray and MRI. This assessment, described as the knee kinesiography exam, quickly provides accurate, reliable, and real-time data of knee joint motion in all three planes while under dynamic and loaded conditions. This exam specifically defines biomechanical dysfunctions, including any dynamic varus/valgus malalignment and thrust that may cause stress on the cartilage at loading. The Emovi KneeKG coupled with cloud AI-powered solutions enables radiologists to generate an objective Consultation Report for their referring physicians, with supportive information to help these clinicians in their medical decision-making process.
Presentations and Exhibit during RSNA:
November 30 at Noon: Emovi will present “A Referring Doctors’ Needs from Radiology” – A point of view and demonstration of the KneeKG System in the Innovation Theater (#4108 in South Hall, level 3).
December 1 at 1:30 pm: Exclusive session hosted by Emovi to present a patients’ journey with the KneeKG through an imaging center, discuss clinical indications, and highlight case studies that demonstrate how a functional assessment can help overcome the limitations of static information from X-rays and MRI. The symposium will take place in S101 AB, South Building – Lower Level.
Register here to save the date: https://emovi.ca/symposium/
Booth #4500: Visitors of RSNA will also be able to engage with Emovi leadership throughout the conference.
About Emovi Inc.
Emovi stands for Emotion • Movement • Vision. These attributes are at the core of who we are as a healthcare innovation company. Our mission is to bring solutions to patients for the treatment of knee injuries and knee osteoarthritis. We are motivated every day by a clear goal: to empower patients to regain their active lifestyle as quickly as possible and enable them to improve their quality of life. Through our AI-powered solutions, we strive to deliver consistent results, positive patient outcomes, and efficiency in patient workflow.
The company is headquartered in Laval, Quebec, Canada. In partnership with the Quebec university research community, including the CRCHUM, Ecole de Technologie superieure(ETS), and TELUQ, Emovi completed the development of the KneeKGTM www.emovi.ca
About The KneeKGTM
The KneeKGTM system is a portable, validated, FDA (510k) cleared, Health Canada Licensed and CE Marked medical device capable of assessing knee motion, in 3D, for patients with impaired movement function of an orthopedic cause, complementing the x-ray and MRI. This assessment, known as Knee Kinesiography, quickly provides accurate, reliable, and real-time data quantifying knee joint motion in all three planes under dynamic and loaded conditions. The exam explicitly defines biomechanical dysfunctions, including any dynamic varus/valgus malalignment and thrust that may be associated with knee pain, instability, stress on the cartilage at loading, and pathology-specific risk factors in osteoarthritis, patella-femoral syndromes, ACL, and others.
The Knee Kinesiography examination is recognized in the most recent clinical practice guidelines of the American Association of Orthopedic Surgeons, with endorsement by the American Association of Hip and Knee Surgeons as an examination creating better patient management, better education, significant reduction in pain, and substantial improvement in knee function.